Profile
ProteinQure has built the best computational platform for designing small exotic protein therapeutics. ProteinQure combines molecular simulations and machine learning to do the structure-based design of drugs. These physics-based methods make ProteinQure less dependent on large data sets, which are relevant for novel chemical matter and difficult disease targets (such as GPCRs, Ion Channels or intracellular protein-protein interactions).
ProteinQure has three collaborations with top 25 pharma companies and has successfully validated its compounds in their experimental assays. The small proteins it specializes in are one of the fastest growing classes of therapeutics with applications across all major disease indications. ProteinQure focuses on using them as therapeutics and as delivery tools (homing peptides). ProteinQure use its computational platform (as well as wetlab validation) to solve its drug design challenges and is now beginning to develop an internal pipeline.
ProteinQure is not selling software; their partnership model involves upfront fees and milestones. The company is now working on its first assets.
Website
Contact
-
Lucas Siow, CEO and Co-FounderTel: +1 647-248-9772Email: lucas@proteinqure.com
-
-
-
-
-
Event details
Event contact
Participants
-
Able Innovations is solving the repetitive and labour-intensive task of patient transfers by developing robotic medical… -
Cohesys is a Toronto-based medical device manufacturer that has developed BoneTape, a resorbable tape for bone fracture… -
EmergConnect aims to change the way patients think about same-day care through a digital platform for patient self-… -
Hyivy Health was created after founder Rachel Bartholomew’s recent fight with cervical cancer. She wanted to change the… -
Nanovista is developing novel, multi-modality imaging agents for oncology. Nanovista is enabling surgical oncologists… -
ProteinQure has built the best computational platform for designing small exotic protein therapeutics. ProteinQure…
-
QuadroCore is pushing the limits within the field of Mass Spectrometer (MS) technology. The company is… -
QurCan therapeutics is a biotech company developing next-generation chemo and gene therapies using its proprietary… -
Quthero is an early-stage life sciences startup developing applications for its platform technology--a unique, patented… -
Translucent Computing’s Emrchiver enables value-based care for better patient outcomes without vendor lock-in.…